Astrana Health, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Astrana Health, Inc. on March 28, 2025, reporting events that occurred on March 26, 2025. The Company is incorporated in Delaware and its common stock trades on The Nasdaq Stock Market LLC under the symbol "ASTH".
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The report focuses exclusively on executive personnel changes and compensation arrangements.
Material Changes
The primary material change reported is the appointment of Glenn W. Sobotka as Chief Accounting Officer and principal accounting officer, effective March 26, 2025. John Vong, the previous Chief Accounting Officer, is transitioning to a new role within the Company and will no longer serve as the principal accounting officer.
Management Commentary and Compensation
Mr. Sobotka brings over 25 years of accounting experience, including prior roles as CFO at Arkos Health, Inc. and Chief Accounting Officer at Carbon Health, Inc. and agilon health, inc. His compensation package includes:
- Base Salary: $320,000 annually.
- Annual Bonus: Discretionary with a target award of 40% of base salary.
- Equity Grant: 6,432 shares of restricted stock vesting in four equal annual installments.
- Performance Equity: 8,269 shares of performance-based restricted stock subject to time and performance conditions.
- Severance: Entitlement to additional severance benefits if terminated without cause or for good reason, subject to a release of claims.
Investor Verification Checklist
- Verify the effective date of John Vong's transition to his new role.
- Review the specific performance conditions attached to the 8,269 shares of performance-based restricted stock.
- Confirm the terms of the severance package and the definition of "good reason" in the employment agreement.
- Check for any subsequent filings regarding the departure of John Vong if he leaves the Company entirely.